SEER Inquiry System - Home


Welcome to the SEER Inquiry System (SINQ). SINQ is a collection of questions that cancer registrars have had while coding cancer cases. Click Search to look for specific questions or to select questions for a Report.


Recent Questions
<< First    < Prev 10    11 to 20 of 1991    Next 10 >    Last >>
Add to Report ID Question Status Last Updated
20170065

MP/H Rules/Histology--Thyroid: How should histology be coded for a single tumor with final diagnosis undifferentiated (anaplastic) carcinoma arising in association with papillary thyroid carcinoma and the Summary Cancer Data states Histologic type: Undifferentiated (anaplastic) carcinoma only? See Discussion.




 

Final Oct 03 2017
20170064

Grade/Histology--Rectum: How should histology and grade be coded for high grade neuroendocrine tumor (NET) (WHO Grade 3) of the rectum? See Discussion.


 

Final Sep 28 2017
20170063

Reportability/Behavior--Ovary: Is adult granulosa cell tumor a reportable malignant tumor if the primary ovarian tumor ruptured intraoperatively, the peritoneum was contaminated, and the patient underwent adjuvant treatment with chemotherapy given the increased risk of recurrence due to intraoperative tumor spill? See Discussion.
 

 

Final Sep 27 2017
20170062

Race, ethnicity:  How do you code race for someone from New Zealand?

Final Sep 21 2017
20170061

MP/H Rules/Histology--Thyroid: What is the correct histology when final diagnosis of a thyroidectomy includes the descriptor "papillary and follicular architecture?" See Discussion.
 

Final Sep 18 2017
20170060

MP/H Rules/Histology/Grade--Unknown & ill-defined sites: What is the correct histology and grade of a liver biopsy with metastatic neuroendocrine carcinoma low to intermediate grade if primary site is unknown? See Discussion.
 

Final Sep 18 2017
20170058

MP/H Rules/Histology--Lung:  What is the correct histology code for an initial biopsy of non-small cell carcinoma with neuroendocrine phenotype, possible large cell neuroendocrine carcinoma with a subsequent re-biopsy showing poorly differentiated small cell carcinoma after chemotherapy with no response? See discussion.

Final Sep 07 2017
20170057

Grade:  If the biopsy site is a higher grade, is the grade of the biopsy used over the grade of the surgical resection?  See Discussion.

Final Sep 05 2017
20170056

Reportability/Histology--Skin:  Is 'skin, left temporal scalp, low grade adnexal carcinoma, probable sweat gland origin' reportable as 8400/3, skin of temple?

Final Sep 05 2017
20170055

First Course of Treatment/Surgery of Primary Site--Corpus uteri:  Do you code total hysterectomy or radical hysterectomy when a specimen indicates the uterus, cervix, ovaries, fallopian tubes, and right and left parametrium were resected, but shows no portion of the vagina.  See Discussion.

Final Sep 01 2017
< Prev 10    Next 10 >